Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating whether DHA supplements improve macular function in patients with Stargardt disease and Stargardt-like macular dystrophy; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DHA supplement (docosahexaenoic acid)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Macular Degeneration | Phase 1 | Status: COMPLETED